<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
Enamelon, Inc.
------------------
(Name of Issuer)
Common Stock. $.001 par value
-------------------------------
(Title of Class of Securities)
292499 10 0
(CUSIP Number)
-----------------------------
Page 1 of 4 pages
<PAGE>
SCHEDULE 13G
CUSIP No. 292499 10 0 Page 2 of 4
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
Dr. Steven R. Fox
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
5) SOLE VOTING POWER
(See item 4)
-------------------------------------------------------
NUMBER 6) SHARED VOTING POWER
OF SHARES None
BENEFICIALLY -------------------------------------------------------
OWNED BY 7) SOLE DISPOSITIVE POWER
EACH (See item 4)
REPORTING -------------------------------------------------------
PERSON WITH 8) SHARED DISPOSITIVE POWER
(See item 4)
- --------------------------------------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,543,240
- --------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
48.2%
- --------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
IN
<PAGE>
Page 3 of 4
Item 1(a). Name of Issuer: Enamelon, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
15 Kimball Avenue
Yonkers, New York 10704
Item 2(a). Name of Person Filing: Dr. Steven R. Fox
Item 2(b). Address of Principal Business Office, or if None,
Residence:
15 Kimball Avenue
Yonkers, New York 10704
Item 2(c). Citizenship: USA
Item 2(d). Title of Class of Securities: Common Stock, $.001 par
value
Item 2(e). CUSIP Number: 292499 10 0
Item 3. If this statement is filed pursuant to Rule
13d-1(b), or 13d-2(b): Not Applicable
Item 4. Ownership:
(a) Amount Beneficially Owned: 3,543,240 shares of Common
Stock including 36,348 shares of Common Stock held in
trust for the benefit of Dr. Fox's minor children.
Also includes 450,000 shares issuable upon exercise
of currently exercisable stock options.
(b) Percent of Class: 48.2%
(c) Number of Shares as to which such person has:
(i) Sole power to vote or to direct the vote:
3,543,240 shares including 450,000 shares of
Common Stock issuable upon the exercise of
currently exercisable options held by Dr. Fox.
(ii) Shared power to vote or to direct the vote: None
(iii) Sole power to dispose or to direct the
disposition of 3,543,240 shares of Common Stock: Dr.
Fox's beneficial ownership of 3,543,240 shares of
Common Stock, including 450,000 shares of Common
Stock issuable upon the exercise of currently
exercisable options are subject to a lock-up
agreement between
<PAGE>
Page 4 of 4
Dr. Fox and Rodman & Renshaw, Inc.("Rodman"), as
representative of the several underwriters of
the Issuer's initial public offering of Common
Stock for a period of 180 days following the
effective date of the Issuer's registration
statement on Form S-1, which was October 23, 1996.
Such lock-up agreement provides that Dr. Fox will
not, without the prior written consent of Rodman,
offer, pledge, sell, transfer, assign, contract to
sell, grant any option for the sale of, or
otherwise dispose of, directly or indirectly, the
above-referenced securities.
(iv) Shared power to dispose or to direct the
disposition of 3,543,240 shares of Common Stock:
See (iii) above.
Items 5-10. Not Applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
February 13, 1997
-------------------
Date
/s/ Dr. Steven R. Fox
------------------------
Dr. Steven R. Fox
Chairman of the Board and
Chief Executive Officer
